Stourbridge care home donates life-saving equipment to school
A STOURBRIDGE care home has donated a potentially life-saving piece of equipment to a primary school.
Parkfield Grange care home gifted a bleed control kit to Netherbrook Primary School.
The kit, which contains equipment to stop severe bleeding, will be used in emergency situations.
Catherine Marshall, assistant head teacher at Netherbrook Primary School, said: "We were absolutely thrilled when a parent of two of our pupils, who works at Parkfield Grange Care Home, shared our fundraising plans with Emily Hocking, the home admissions advisor.
"Emily kindly reached out and generously donated a bleed control kit.
"We cannot thank Parkfield Grange enough for helping us access this vital emergency equipment that could one day save lives.
"This donation not only enhances the safety of our pupils and staff but also means we're better prepared to support our wider community in the event of an emergency."
Emily Hocking, home admissions advisor at Parkfield Grange, said: "We are part of a vibrant and caring community and when our colleague informed us of Netherbrook's plan to raise funds for a bleed control kit, we were delighted to donate one.
"Having such a kit in a community setting can save lives before paramedics arrive."
Parkfield Grange, which is located on the Hagley Road in Stourbridge, offers 68 large en-suite bedrooms and six one-bedroom care suites, all furnished.
The care suites include an en-suite bedroom, lounge, and kitchenette and although developed with couples in mind, are ideal for those looking for more space and privacy than a traditional care bedroom.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Mass rollout of weight loss jabs begins on NHS today - are you eligible?
An NHS mass rollout of weight loss jabs Mounjaro on the NHS in England will begin on Monday as GPs are allowed to prescribe the drugs for the first time. Around 220,000 people with 'greatest need' are expected to receive Mounjaro, also known as tirzepatide and made by Lilly through the NHS over the next three years. Around 29% of the adult population in the UK is obese. The drug is an antidiabetic drug which lowers blood sugar levels and and slows down how quickly food is digested. From today, GPs in England will be allowed to prescribe Mounjaro to severely obese people who also suffer from a range of other health problems. Patients previously needed to access the drugs through a special weight loss service. But leading family doctors said some GPs have expressed concern about the additional workload linked to the rollout. Coming up on GMB 👇 📰 There are fears that the UK will face terror attacks as Iran vows revenge on America and its allies. 📰 The mass rollout of the weight-loss jab Mounjaro on the NHS in England begins today, but GPs and pharmacists warn of increased workloads and a lack of… — Good Morning Britain (@GMB) June 23, 2025 And pharmacy experts also said there could be pressure on supplies of the drug. In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of over 40 who have at least four other health problems linked to obesity, such as type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea. Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed through specialist weight loss services or via private prescription. Dr Claire Fuller, from NHS England, said: 'This is an important next step in the rollout of weight loss drugs, with community-based services now able to offer this treatment from today. 'We urgently need to address rising levels of obesity and prioritise support for those who are experiencing severe ill health – and greater access to weight loss drugs will make a significant difference to the lives of those people. 'These drugs are an important tool alongside the range of wraparound NHS support and advice on good nutrition and increasing physical activity, which will be vital in helping some people lose weight and reduce their risk of serious long-term conditions. 'While not everyone will be eligible for weight loss drugs, it's important that anyone who is worried about the impact of their weight on their health discusses the range of NHS support available with their healthcare professional.' Recommended reading: Mounjaro heatwave warning as temperatures soar Mounjaro warning for anyone planning a holiday When will Mounjaro be rolled out on the NHS? Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: 'While we recognise the potential benefits of weight loss drugs, we know many GPs are concerned about the implications of the rollout of weight loss drugs into general practice, both in terms of workload and training to appropriately initiate and manage these treatments. 'The college shares these concerns, which is why we were pleased NHS England suggested a phased roll-out of Mounjaro as a treatment for weight loss. As and when this is escalated, appropriate resourcing for general practice – including access to 'wraparound' services – and training for GPs must follow. She added: 'GPs and our teams are already working under intense workload and workforce pressures, and this must be factored into this rollout in order to guarantee it can be delivered safely. 'More widely, whilst weight loss medications have a lot of potential benefits for patients who are struggling to lose weight and who meet all the clinical criteria for a prescription, they mustn't be seen as a 'silver bullet' to aid weight loss. 'We also need to see a focus on prevention, stopping people becoming overweight in the first place so they don't require a medical intervention later.' Dr Hawthorne said there is no 'one size fits all approach' and that the rollout of the jabs should not 'come at the expense of other weight loss service'. She continued: 'The roll-out of weight loss medications in the NHS will need to be consistently evaluated to ensure that there is evidence that these prescriptions are of long-term benefit to patients.' Olivier Picard, chairman of the National Pharmacy Association, said: 'The demand for weight loss jabs continues to rise sharply, and more GPs have been directing patients back to pharmacies after initial inquiries, to access these treatments privately. 'As the NHS is now moving to implement National Institute for Health and Care Excellence (Nice) guidance, and tirzepatide becomes prescribable to more patients, we expect to see prescription volumes increase rapidly. 'However, NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately from a pharmacy. 'Pharmacists are experts in medication and many of us have lots of experience delivering weight loss injections as part of a package of care including lifestyle advice. 'We are well placed to help roll out weight loss treatment on the NHS, with the right funding to support it. 'The biggest concern we have is that prescribing these medications alone misses the point. 'They should be part of a comprehensive weight management strategy – combining lifestyle coaching, exercise, and nutritional guidance. In reality, many GPs lack the bandwidth to deliver the level of support needed to ensure proper understanding and follow-up. 'As a result, we could end up in a situation where patients are prescribed the medication, lose weight, and then experience rebound weight gain once the course ends – simply because the foundational lifestyle changes weren't addressed.'
Bloomberg
2 hours ago
- Bloomberg
PHP Raises Assura Bid to £1.79 Billion in Latest Fight With KKR
A takeover battle for one of London's healthcare REITs took a new turn after the board switched its recommendation from an all-cash private equity offer to a sweetened one by a listed player. Assura Plc 's board announced that it was recommending an increased cash and share offer from industry rival Primary Health Properties Plc over a consortium led by KKR & Co. The latest PHP offer valued Assura at roughly £1.79 billion ($2.4 billion).
Yahoo
3 hours ago
- Yahoo
Double trek made cancer survivor 'feel alive'
A woman in remission with leukaemia said finishing two gruelling challenges in a week made her feel "really alive". Lesley Calder, from Bishop Stortford, Hertfordshire, climbed Ben Nevis and walked the Highlands Coast to Coast to raise funds for blood cancer charity, DKMS. The 59-year-old received a lifesaving stem cell transplant from her sister in 2019 and said she was keen to challenge herself again after completing a similar trek before she became ill. "[Back] then I felt fit and well, it wasn't a struggle in anyway - this was a lot tougher, without a doubt the hardest physical challenge I've ever done," she said. "It nearly killed me, but I did it." Mrs Calder ascended 1345m (4,413ft) to the top of Ben Nevis on 30 May and two days later began the 120km (75-mile) Great Glen Way challenge with six friends, reaching journey's end on 6 June. She said she "picked up where we left off" at the West Highland Way, which she completed 10 years ago, before being diagnosed with acute myeloid leukaemia. "I wanted to feel like I was pushing myself, I was extremely emotional and I'm not a hugely emotional person," she said. "It sounds trite to say it, but I was pleased to be alive, it made me feel really alive." DKMS spokesperson Anna Norman said Mrs Calder was "absolutely amazing". "The fact that she was able take on a huge challenge like this shows how stem cell transplants can totally transform people's lives." Follow Beds, Herts and Bucks news on BBC Sounds, Facebook, Instagram and X. Sister's stem cells help woman fight leukaemia DKMS
